Sign up


Match Document Document Title
7125861 Water-soluble chitosan-indole-3-propionic acid conjugates  
Water-soluble chitosan-indole-3-propionic acid conjugates useful as active constituents in pharmaceutical as well as cosmeceutical and agricultural applications are described.
7119079 Bioadhesive pharmaceutical compositions  
Disclosed are compounds having the formula wherein R2 is hydrogen, a monomeric glycoside or an oligomeric glycoside, R3 is hydrogen, a monomeric glycoside, an oligomeric glycoside, or a group...
7115588 Methods for treating a breach or puncture in a blood vessel  
The present invention relates to compositions comprising semi-crystalline β-1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymers modulation of vascular structure and/or ...
RE39321 Supplemented and unsupplemented tissue sealants, methods of their production and use  
This invention provides a fibrin sealant dressing, wherein said fibrin sealant may be supplemented with at least one composition selected from, for example, one or more regulatory compounds,...
7113821 Tissue electroperforation for enhanced drug delivery  
The present invention relates to a method and a device for transporting a molecule through a mammalian barrier membrane of at least one layer of cells comprising the steps of: ablating the membrane...
7112576 Compositions and methods for cryopreservation of peripheral blood lymphocytes  
A composition and method for cryopreserving cells in a non-toxic medium is described. The composition and method provide cells for cell therapy and other in vivo applications.
7109182 Synthetic oligomannosides, preparation and uses thereof  
A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious...
7109175 Specific steady-state R-type CA2+ channel blockers and use thereof  
The present invention relates to Ca2+ channel blockers and more particularly to the R-type Ca2+ channel blockers. More specifically, the invention relates to Ca2+ channel blockers activity of...
7105571 Prostaglandin compositions and methods of treatment for male erectile dysfunction  
The invention provides methods and compositions for treating erectile dysfunction. The methods include the step of placing within the fossa navicularis of the patient an effective erection-inducing...
7101562 Conjugate vaccines for the prevention of dental caries  
The present invention provides glucan-based compositions and methods for stimulating an immune response against mutans streptococci components and vaccines and methods for the treatment and...
7101862 Hemostatic compositions and methods for controlling bleeding  
The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g.,...
7101863 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative  
The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising, (1) at least a dextran derivative of general...
7101859 Use of lipid conjugates in the treatment of diseases  
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers....
7098193 Compositions comprising a defined polysaccharide component  
The present disclosure provides compositions comprising an extracted portion of psyllium seed in combination with one or more of a binder, suspending agent, or edible acid. In particular, the...
7098194 Composition and method to homogeneously modify or cross-link chitosan under neutral conditions  
In accordance with the present invention there is provided a new composition and method for chemically modifying chitosan, including N-substituting or N-cross-linking, under homogeneous conditions...
RE39245 Galactopyranosides and their use  
The present invention relates to simplified synthesis, new carbohydrate-based products and practical use of different carbohydrate-based products. Examples of these are (Galα1-3Gal), ...
7091191 Modified hyaluronic acid for use in musculoskeletal tissue repair  
The present invention includes hyaluronic acid complexes of a monovalent alkali metal salt of hyaluronic acid and a tetra alkyl ammonium halide that are suitable for incorporation with tissue...
7090857 Antigenic preparations  
The present invention relates to antigenic preparations comprising polysaccharides and/or glycopeptides preparable from keratinophilic fungi as well as yeasts, process for the preparation of these...
7090856 Anti-fouling exopolysaccharides isolated from cultures of Vibrio alginolyticus and Vibrio proteolyticus  
An anti-fouling agent derived by culturing Vibrio alginolyticus in a suitable aqueous solution as well as a newly isolated strain of V. alginolyticus (DSM 15590) for producing the anti-fouting...
7084130 Intraocular irrigating solution having improved flow characteristics  
Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular surgical procedures by reducing the turbulence of the...
7084112 Activated polyethylene glycol compounds  
Novel arylisothiocyanate compounds are described that are useful for activating alcohol-containing macromolecules, for example polyethyleneglycols and cellulose, for covalent linkage to...
7084107 Methods for stabilizing liquid nutritional products and products so stabilized  
Nutritional solutions and methods of making same are disclosed. The solutions include protein, lipid, and a carbohydrate source including high amylose starch and guar gum.
7084132 Artemisinins with improved stability and bioavailability for therapeutic drug development and application  
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation ...
7084131 Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition  
A method for preparing a polydispersed saccharide composition in which a fructan-containing material is dissolved in water prior to partial enzymatic treatment of the fructans.
7081450 Water soluble nanoparticles of hydrophilic and hydrophobic active materials and an apparatus and method for their production  
This invention provides a soluble nano-sized particles formed of a core (water-insoluble lipophilic compound or hydrophilic compound) and an amphiphilic polymer and which demonstrated improved...
7070778 Therapeutical combination against cancer  
The present invention relates to compositions and methods for treating humans and warm-blood animals suffering from cancer. More particularly, a therapeutical treatment in which a monoclonal...
7071233 Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases  
An improved medical treatment and medicine is provided to quickly and safely resolve HIV and other microbial infections. The inexpensive medicine can be self administered and maintained for the...
7067479 Compositions with enhanced antimicrobial efficacy against E. coli  
Ophthalmic compositions include a polycation material to enhance antimicrobial efficacy against bacteria such as E. coli. The compositions include eye drop and contact lens treating solutions. A...
7067498 Polymer controlled induced viscosity fiber system and uses thereof  
The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced...
7067499 Cationic polymer composition and its use in conditioning applications  
A composition of a cationic polygalactomannan or a derivative of cationic polygalactomannans is provided that has a mean average molecular weight (Mw) having a lower limit of 5,000 and an upper...
7064104 Methods of managing the symptoms of premenstrual syndrome  
Methods of increasing the tryptophan:LNAA ratio in blood of an individual are taught. Such methods are useful in managing conditions such as premenstrual syndrome, perimenopause, menopause,...
7064114 Gel-microemulsion formulations  
A pharmaceutical composition adapted for use as a spermicide, the composition comprising a gel-microemulsion comprising an oil-in-water microemulsion and a polymeric hydrogel. The gel-microemulsion...
7060691 Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases  
A pharmaceutical colloidal preparation useful in the treatment of diseases of the upper and lower respiratory tract, and lung parenchyma which contains, as an active ingredient, a colloidal mixture...
7060685 Compounds and methods for inhibiting selectin-mediated function  
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the...
7056891 Method to produce a tampon that inhibits exoprotein production from gram positive bacteria  
A method to inhibit the production of exoproteins from Gram positive bacteria, such as harmful proteins produced by Staphylococcus species, is described. The method is particularly useful to...
7056901 Microgel particles for the delivery of bioactive materials  
Novel microgels, microparticles and related polymeric materials capable of delivering bioactive materials to cells for use as vaccines or therapeutic agents. The materials are made using a...
7053066 Food composition and weight loss method for treating obesity  
The invention relates to a method for treating overweight persons or patients with obesity using a food composition able to control the release of glucose into the patient's blood. This is achieved...
7053068 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use  
By the reaction of chitosan with iminothiolactones such as 2-iminothiolane, thiol groups can be covalently immobilized on the polymer. The resulting chitosan derivatives exhibit thiol groups which...
7053150 Segmented polymers and their conjugates  
Segmented water soluble polymers, containing a higher molecular weight segment linked to a lower molecular weight segment, are described. In one embodiment, the polymer segments are poly(ethylene...
7048937 Methods and compositions for control of coccidiosis  
Feeding yeast cell wall-containing compositions, including those compositions comprising mannanoligosaccharide(s), to animals exposed to or infected with coccidia, especially poultry exposed to...
7048918 Insect bait  
Disclosed are insect baits for attracting insects such as ants, flies and cockroaches. The baits include amino acids and a sugar. The baits can be combined with an insect toxicant to effectively...
7049339 Composition for the treatment of diseases which affect animals' hooves  
A composition for treating a disease affecting the hoof of an animal comprising an active ingredient and a colloid former is described. The active ingredient may comprise zinc sulphate, copper...
7045155 Dietary supplements comprising soy hypocotyls containing at least one isoflavone  
Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules...
7041651 Cellular uptake of bioactive agents  
Provided is a composition and a method for increasing cellular uptake of bioactive agents, particularly those compounds termed “small molecules” into the cells of mammalian tissue, such as the epi...
7041656 Sulfated fucoglucuronomannan  
An enzyme which decomposes a sulfated fucoglucuronomannan and is useful in the field of glycotechnology; a process for producing the enzyme; a fucoidan fraction reduced in the number of the kinds...
7041655 Capillary membrane stabilization and reduction of tissue injury through use of IV biodegradable macromolecules with antioxidants and/or other chemicals  
In accordance with the invention there is provided a method of treating a human subject to prevent leakage of serum proteins from capillary endothelial junctions during a period of increased...
7041657 Compositions and methods for modulation of vascular structure and/or function  
The present invention relates to compositions comprising semi-crystalline β-1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymers modulation of vascular structure and/or ...
7034006 Use of lipid conjugates in the treatment of disease  
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers....
7030101 Compositions of β-glucans and specific antibodies  
Compositions and kits comprising combinations of β-glucans and specific immunoglobulins are disclosed. The compositions and kits are useful in methods of preventing or treating infection by a ...
7029883 Preparation of an Auricularia auricula polysaccharide and its use in mammals  
A method for producing a purified Auricularia auricula Polysaccharide (AP) extract of Auricularia auricula (AA). A hydrated predetermined amount of AA is filtered and extracted, producing a first...